Pharmacy Groups Ask FDA to Delay Enforcement of 'Track & Trace' Requirement

Pharmacy Groups Ask FDA to Delay Enforcement of 'Track & Trace' Requirement

ALEXANDRIA, Va. (June 24, 2015) – Three leading pharmacy organizations have asked the Food and Drug Administration (FDA) to help avoid any potential disruptions in the pharmaceutical supply chain by delaying enforcement of a July 1 product tracing deadline for dispensers. The American Pharmacists Association, National Alliance of State Pharmacy Associations and National Community Pharmacists Association made the request in a joint letter to FDA.

"With the December, 2014 FDA enforcement discretion delaying enforcement of the product tracing requirements until May 1, 2015, this implementation timetable has been compressed. Our organizations remain concerned that despite the extensive efforts by pharmacy and wholesale distributor associations to educate dispensers, some trading partners will encounter challenges beyond their control, with the possible outcome of disruptions in the supply chain," leaders of the three organizations wrote. "In order to forestall potential disruptions in the pharmaceutical supply chain, the undersigned organizations respectfully request that FDA utilize its enforcement discretion to delay the July 1 product tracing deadline for dispensers. Our members fully intend to continue intense, concerted efforts toward full compliance, but by exercising its enforcement authority, FDA would allow progress to continue while minimizing the risk of product shortages or disrupting patient access to prescription drugs."

Click here to view a copy of the full letter.

###The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of nearly 23,000 independent community pharmacies. Together they represent an $88.8 billion health care marketplace, dispense nearly 40% of all retail prescriptions, and employ more than 300,000 individuals, including over 62,000 pharmacists. To learn more, go to,, or follow NCPA on Twitter@Commpharmacy.

Kevin Schweers / John Norton

(703) 683-8200

[email protected] / [email protected]


Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.